Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-16 3:30 pm Sale | 13G | IMMUNOMEDICS INC IMMU | Point72 Asset Management L.P. | 0 0.000% | -10,954,266 (Position Closed) | View |
2020-11-09 4:31 pm Sale | 13G | IMMUNOMEDICS INC IMMU | BlackRock Inc. BLK | 0 0.000% | -14,696,596 (Position Closed) | View |
2020-10-23 5:25 pm Sale | 13D | IMMUNOMEDICS INC IMMU | Avoro Capital Advisors LLC | 0 0.000% | -21,000,000 (Position Closed) | View |
2020-04-16 5:26 pm Purchase | 13G | IMMUNOMEDICS INC IMMU | Point72 Asset Management L.P. | 10,954,266 5.100% | 10,954,266 (New Position) | View |
2020-02-14 1:29 pm Sale | 13G | IMMUNOMEDICS INC IMMU | PRICE T ROWE ASSOCIATES INC | 5,827,991 2.700% | -6,987,032 (-54.52%) | View |
2020-02-12 09:26 am Purchase | 13G | IMMUNOMEDICS INC IMMU | VANGUARD GROUP INC | 16,283,773 7.810% | 1,683,088 (+11.53%) | View |
2020-02-07 11:22 am Sale | 13G | IMMUNOMEDICS INC IMMU | FMR LLC | 4,615,579 2.215% | -8,060,551 (-63.59%) | View |
2020-02-05 11:45 am Purchase | 13G | IMMUNOMEDICS INC IMMU | BlackRock Inc. BLK | 14,696,596 7.100% | 2,057,246 (+16.28%) | View |